These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25419391)

  • 1. Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?
    Sahin FK; Sahin SB; Balik G; Ural UM; Tekin YB; Cure MC; Senturk S; Yuce S; Cure E
    Int J Clin Exp Med; 2014; 7(10):3512-9. PubMed ID: 25419391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation.
    Wyskida K; Franik G; Choręza P; Pohl N; Markuszewski L; Owczarek A; Madej P; Chudek J; Olszanecka-Glinianowicz M
    Int J Endocrinol; 2020; 2020():1380176. PubMed ID: 32934654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is pentraxin 3 a new cardiovascular risk marker in polycystic ovary syndrome?
    Sari U; Kaygusuz I; Kafali H
    Gynecol Obstet Invest; 2014; 78(3):173-8. PubMed ID: 25011417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.
    Yilmaz MA; Duran C; Basaran M
    J Endocrinol Invest; 2016 Jan; 39(1):45-53. PubMed ID: 26100531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
    Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
    Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentraxin 3 as a marker of endothelial dysfunction in young women with polycystic ovary syndrome (PCOS).
    Wyskida K; Franik G; Pohl N; Markuszewski L; Owczarek A; Madej P; Chudek J; Olszanecka-Glinianowicz M
    Scand J Clin Lab Invest; 2019 Oct; 79(6):419-423. PubMed ID: 31282210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study.
    Jin C; Zou K; Xu Y; Yang H; Pan J
    BMC Endocr Disord; 2021 Dec; 21(1):240. PubMed ID: 34856980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
    Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
    Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia.
    Papalou O; Livadas S; Karachalios A; Tolia N; Kokkoris P; Tripolitakis K; Diamanti-Kandarakis E
    Hormones (Athens); 2015; 14(1):91-100. PubMed ID: 25553762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome.
    Mažibrada I; Djukić T; Perović S; Plješa-Ercegovac M; Plavšić L; Bojanin D; Bjekić-Macut J; Simić PD; Simić T; Savić-Radojević A; Mastorakos G; Macut D
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1213-1220. PubMed ID: 30335612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.